IRCT201202209083N1已完成未知
Autologous Adult Stem Cell Induced-Lymphangiogenesis in Peripheral Lymphedema
Staff of Stemcell ,By Shahid Beheshti of Medical University0 个研究点目标入组 5 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16 years 至 50 years（—）
- 性别
- All
入选标准
- •Inclusion:/ Congential Atresia or Hypoplasia of Lymphatic Vesseles
- •Exclusion Criteria :/Inflamatory Malignant Disease
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Controlled trial to assess low intensity autologous stem cell transplant in refractory Crohn's DiseaseEUCTR2017-002545-30-GBBarts Health NHS Trust99
进行中（未招募）
1 期
Stem Cell Transplantation and Maintenance Therapy with Thalidomide / DLI for patients with Multiple MyelomaEUCTR2007-004928-21-DEniversity Medical Center Hamburg-Eppendorf220
已完成
不适用
Autologous peripheral blood stem cell transplantation using Thiotepa, Carboplatin and Etoposide conditioning in patients with relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)relapsed or refractory Medulloblastoma, Primitive neuroectodermal tumor (PNET) and Atypical teratoma and rhabdoid tumor (ATRT)JPRN-UMIN000026084agoya University Graduate School of Medicine10
已完成
不适用
Autologous peripheral blood stem cell transplantation as consolidation for high risk diffuse large B-cell lymphoma:A phase II studyDiffuse Large B-Cell Lymphoma:IPI high risk group, CR1JPRN-UMIN000012546ishiwaki Municipal Hospital18
招募中
不适用
Autologous peripheral blood stem cell transplantation for elderly patients (65-74 years old) with multiple myeloma.multiple myelomaJPRN-UMIN000038905Tokyo-Kita Medical Center20